{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:00:01Z","timestamp":1790478001243,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-226","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T17:01:54Z","timestamp":1412182914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation"],"prefix":"10.1186","volume":"13","author":[{"given":"Ming-Xuan","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ze","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ren","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J: Hepatocellular carcinoma. Lancet. 2012, 379: 1245-1255. 10.1016\/S0140-6736(11)61347-0","journal-title":"Lancet"},{"key":"1431_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006, 6: 674-687. 10.1038\/nrc1934","journal-title":"Nat Rev Cancer"},{"key":"1431_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semcancer.2010.10.007","volume":"21","author":"JD Yang","year":"2011","unstructured":"Yang JD, Nakamura I, Roberts LR: The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets. Semin Cancer Biol. 2011, 21: 35-43. 10.1016\/j.semcancer.2010.10.007","journal-title":"Semin Cancer Biol"},{"key":"1431_CR4","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jhep.2014.02.025","volume":"60","author":"J Li","year":"2014","unstructured":"Li J, Yang XM, Wang YH, Feng MX, Liu XJ, Zhang YL, Huang S, Wu Z, Xue F, Qin WX, Gu JR, Xia Q, Zhang ZG: Monoamine oxidase A suppresses Hepatocellular Carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling. J Hepatol. 2014, 60: 1225-1234. 10.1016\/j.jhep.2014.02.025","journal-title":"J Hepatol"},{"key":"1431_CR5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes RO: The extracellular matrix: not just pretty fibrils. Science. 2009, 326: 1216-1219. 10.1126\/science.1176009","journal-title":"Science"},{"key":"1431_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neo.2014.03.001","volume":"16","author":"MZ Ma","year":"2014","unstructured":"Ma MZ, Zhuang C, Yang XM, Zhang ZZ, Ma H, Zhang WM, You H, Qin W, Gu J, Yang S, Cao H, Zhang ZG: CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt\/PCP-Rho signaling. Neoplasia. 2014, 16: 265-278. 278 e261-213, 10.1016\/j.neo.2014.03.001","journal-title":"Neoplasia"},{"key":"1431_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm843","volume":"9","author":"QH Ye","year":"2003","unstructured":"Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 2003, 9: 416-423. 10.1038\/nm843","journal-title":"Nat Med"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/hep.21936","volume":"46","author":"C Bergamini","year":"2007","unstructured":"Bergamini C, Sgarra C, Trerotoli P, Lupo L, Azzariti A, Antonaci S, Giannelli G: Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins. Hepatology. 2007, 46: 1801-1809. 10.1002\/hep.21936","journal-title":"Hepatology"},{"key":"1431_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/hep.24479","volume":"54","author":"H Li","year":"2011","unstructured":"Li H, Ge C, Zhao F, Yan M, Hu C, Jia D, Tian H, Zhu M, Chen T, Jiang G, Xie H, Cui Y, Gu J, Tu H, He X, Yao M, Liu Y, Li J: Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1\/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology. 2011, 54: 910-919. 10.1002\/hep.24479","journal-title":"Hepatology"},{"key":"1431_CR10","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.18632\/oncotarget.2239","volume":"5","author":"Y Fu","year":"2014","unstructured":"Fu Y, Feng MX, Yu J, Ma MZ, Liu XJ, Li J, Yang XM, Wang YH, Zhang YL, Ao JP, Xue F, Qin W, Gu J, Xia Q, Zhang ZG: DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by alpha3beta1 integrin-Rho GTPase signaling. Oncotarget. 2014, 5: 6701-15.","journal-title":"Oncotarget"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1101\/gad.12.1.21","volume":"12","author":"C Hidai","year":"1998","unstructured":"Hidai C, Zupancic T, Penta K, Mikhail A, Kawana M, Quertermous EE, Aoka Y, Fukagawa M, Matsui Y, Platika D, Auerbach R, Hogan BL, Snodgrass R, Quertermous T: Cloning and characterization of developmental endothelial locus-1: An embryonic endothelial cell protein that binds the alpha vbeta 3 integrin receptor. Genes Dev. 1998, 12: 21-33. 10.1101\/gad.12.1.21","journal-title":"Genes Dev"},{"key":"1431_CR12","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1096\/fj.11-202036","volume":"26","author":"T Schurpf","year":"2012","unstructured":"Schurpf T, Chen Q, Liu JH, Wang R, Springer TA, Wang JH: The RGD finger of Del-1 is a unique structural feature critical for integrin binding. FASEB J. 2012, 26: 3412-3420. 10.1096\/fj.11-202036","journal-title":"FASEB J"},{"key":"1431_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI17034","volume":"112","author":"J Zhong","year":"2003","unstructured":"Zhong J, Eliceiri B, Stupack D, Penta K, Sakamoto G, Quertermous T, Coleman M, Boudreau N, Varner JA: Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest. 2003, 112: 30-41. 10.1172\/JCI17034","journal-title":"J Clin Invest"},{"key":"1431_CR14","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1161\/01.CIR.0000118465.36018.2D","volume":"109","author":"HKV Ho","year":"2004","unstructured":"Ho HKV: Developmental Endothelial Locus-1 (Del-1), a Novel Angiogenic Protein: Its Role in Ischemia. Circulation. 2004, 109: 1314-1319. 10.1161\/01.CIR.0000118465.36018.2D","journal-title":"Circulation"},{"key":"1431_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1126\/science.1165218","volume":"322","author":"EY Choi","year":"2008","unstructured":"Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, Ballantyne CM, Constant SL, Aird WC, Papayannopoulou T, Gahmberg CG, Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T: Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science. 2008, 322: 1101-1104. 10.1126\/science.1165218","journal-title":"Science"},{"key":"1431_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.molonc.2013.08.004","volume":"6","author":"H Damhofer","year":"2013","unstructured":"Damhofer H, Medema JP, Veenstra VL, Badea L, Popescu I, Roelink H, Bijlsma MF: Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma. Mol Oncol. 2013, 6: 1031-42.","journal-title":"Mol Oncol"},{"key":"1431_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.clcc.2011.03.011","volume":"10","author":"T Watanabe","year":"2011","unstructured":"Watanabe T, Kobunai T, Yamamoto Y, Ikeuchi H, Matsuda K, Ishihara S, Nozawa K, Iinuma H, Kanazawa T, Tanaka T, Yokoyama T, Konishi T, Eshima K, Ajioka Y, Hibi T, Watanabe M, Muto T, Nagawa H: Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis. Clin Colorectal Cancer. 2011, 10: 134-141. 10.1016\/j.clcc.2011.03.011","journal-title":"Clin Colorectal Cancer"},{"key":"1431_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.juro.2014.02.035","volume":"192","author":"CJ Beckham","year":"2014","unstructured":"Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK, Scosyrev E, Messing EM, Lee YF: Bladder Cancer Exosomes Contain EDIL-3\/Del1 and Facilitate Cancer Progression. J Urol. 2014, 192: 583-592. 10.1016\/j.juro.2014.02.035","journal-title":"J Urol"},{"key":"1431_CR19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/hep.21328","volume":"44","author":"JH Luo","year":"2006","unstructured":"Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, Ranganathan S, Michalopoulos GK: Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology. 2006, 44: 1012-1024.","journal-title":"Hepatology"},{"key":"1431_CR20","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.3748\/wjg.v16.i36.4611","volume":"16","author":"J-C Sun","year":"2010","unstructured":"Sun J-C: High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients. World J Gastroenterol. 2010, 16: 4611- 10.3748\/wjg.v16.i36.4611","journal-title":"World J Gastroenterol"},{"key":"1431_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P: Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012, 226: 380-393. 10.1002\/path.3000","journal-title":"J Pathol"},{"key":"1431_CR22","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1242\/jcs.072165","volume":"124","author":"MC Guadamillas","year":"2011","unstructured":"Guadamillas MC, Cerezo A, Del Pozo MA: Overcoming anoikis\u2013pathways to anchorage-independent growth in cancer. J Cell Sci. 2011, 124: 3189-3197. 10.1242\/jcs.072165","journal-title":"J Cell Sci"},{"key":"1431_CR23","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1242\/jcs.00071","volume":"115","author":"DG Stupack","year":"2002","unstructured":"Stupack DG, Cheresh DA: Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci. 2002, 115: 3729-3738. 10.1242\/jcs.00071","journal-title":"J Cell Sci"},{"key":"1431_CR24","doi-asserted-by":"publisher","first-page":"11101","DOI":"10.1074\/jbc.274.16.11101","volume":"274","author":"K Penta","year":"1999","unstructured":"Penta K, Varner JA, Liaw L, Hidai C, Schatzman R, Quertermous T: Del1 induces integrin signaling and angiogenesis by ligation of alphaVbeta3. J Biol Chem. 1999, 274: 11101-11109. 10.1074\/jbc.274.16.11101","journal-title":"J Biol Chem"},{"key":"1431_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.surg.2011.07.013","volume":"151","author":"Z Wang","year":"2012","unstructured":"Wang Z, Kundu RK, Longaker MT, Quertermous T, Yang GP: The angiogenic factor Del1 prevents apoptosis of endothelial cells through integrin binding. Surgery. 2012, 151: 296-305. 10.1016\/j.surg.2011.07.013","journal-title":"Surgery"},{"key":"1431_CR26","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.111.068833","volume":"125","author":"SK Dasgupta","year":"2012","unstructured":"Dasgupta SK, Le A, Chavakis T, Rumbaut RE, Thiagarajan P: Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation. 2012, 125: 1664-1672. 10.1161\/CIRCULATIONAHA.111.068833","journal-title":"Circulation"},{"key":"1431_CR27","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.4049\/jimmunol.172.6.3876","volume":"172","author":"R Hanayama","year":"2004","unstructured":"Hanayama R, Tanaka M, Miwa K, Nagata S: Expression of developmental endothelial locus-1 in a subset of macrophages for engulfment of apoptotic cells. J Immunol. 2004, 172: 3876-3882. 10.4049\/jimmunol.172.6.3876","journal-title":"J Immunol"},{"key":"1431_CR28","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.bbrc.2005.06.009","volume":"333","author":"M Aoki","year":"2005","unstructured":"Aoki M, Kanamori M, Ohmori K, Takaishi M, N-h H, Nogami S, Kimura T: Expression of developmentally regulated endothelial cell locus 1 was induced by tumor-derived factors including VEGF. Biochem Biophys Res Commun. 2005, 333: 990-995. 10.1016\/j.bbrc.2005.06.009","journal-title":"Biochem Biophys Res Commun"},{"key":"1431_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ni.2260","volume":"13","author":"MA Eskan","year":"2012","unstructured":"Eskan MA, Jotwani R, Abe T, Chmelar J, Lim JH, Liang S, Ciero PA, Krauss JL, Li F, Rauner M, Hofbauer LC, Choi EY, Chung KJ, Hashim A, Curtis MA, Chavakis T, Hajishengallis G: The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol. 2012, 13: 465-73. 10.1038\/ni.2260","journal-title":"Nat Immunol"},{"key":"1431_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/jhep.2002.34611","volume":"36","author":"M Nejjari","year":"2002","unstructured":"Nejjari M, Hafdi Z, Gouysse G, Fiorentino M, Beatrix O, Dumortier J, Pourreyron C, Barozzi C, D'Errico A, Grigioni WF, Scoazec JY: Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology. 2002, 36: 418-426. 10.1053\/jhep.2002.34611","journal-title":"Hepatology"},{"key":"1431_CR31","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1038\/onc.2011.89","volume":"30","author":"JV Burnier","year":"2011","unstructured":"Burnier JV, Wang N, Michel RP, Hassanain M, Li S, Lu Y, Metrakos P, Antecka E, Burnier MN, Ponton A, Gallinger S, Brodt P: Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 2011, 30: 3766-3783. 10.1038\/onc.2011.89","journal-title":"Oncogene"},{"key":"1431_CR32","first-page":"3481","volume":"2013","author":"P Paoli","year":"1833","unstructured":"Paoli P, Giannoni E, Chiarugi P: Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 1833, 2013: 3481-98.","journal-title":"Biochim Biophys Acta"},{"key":"1431_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA: Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010, 10: 9-22. 10.1038\/nrc2748","journal-title":"Nat Rev Cancer"},{"key":"1431_CR34","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/nm.2009","volume":"15","author":"JS Desgrosellier","year":"2009","unstructured":"Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prevost N, Tarin D, Shattil SJ, Cheresh DA: An integrin alpha (v) beta (3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med. 2009, 15: 1163-1169. 10.1038\/nm.2009","journal-title":"Nat Med"},{"key":"1431_CR35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/jcb.22131","volume":"107","author":"MJ Demers","year":"2009","unstructured":"Demers MJ, Thibodeau S, Noel D, Fujita N, Tsuruo T, Gauthier R, Arguin M, Vachon PH: Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK\/Erk and\/or PI3-K\/Akt-1. J Cell Biochem. 2009, 107: 639-654. 10.1002\/jcb.22131","journal-title":"J Cell Biochem"},{"key":"1431_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10495-012-0713-6","volume":"17","author":"M Beausejour","year":"2012","unstructured":"Beausejour M, Noel D, Thibodeau S, Bouchard V, Harnois C, Beaulieu JF, Demers MJ, Vachon PH: Integrin\/Fak\/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis. 2012, 17: 566-578. 10.1007\/s10495-012-0713-6","journal-title":"Apoptosis"},{"key":"1431_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","volume":"18","author":"SK Mitra","year":"2006","unstructured":"Mitra SK, Schlaepfer DD: Integrin-regulated FAK\u2013Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006, 18: 516-523. 10.1016\/j.ceb.2006.08.011","journal-title":"Curr Opin Cell Biol"},{"key":"1431_CR38","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1038\/sj.onc.1204619","volume":"20","author":"NI Kozlova","year":"2001","unstructured":"Kozlova NI, Morozevich GE, Chubukina AN, Berman AE: Integrin alphavbeta3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells. Oncogene. 2001, 20: 4710-4717. 10.1038\/sj.onc.1204619","journal-title":"Oncogene"},{"key":"1431_CR39","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1158\/0008-5472.CAN-08-1839","volume":"68","author":"N Rohwer","year":"2008","unstructured":"Rohwer N, Welzel M, Daskalow K, Pfander D, Wiedenmann B, Detjen K, Cramer T: Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Res. 2008, 68: 10113-10120. 10.1158\/0008-5472.CAN-08-1839","journal-title":"Cancer Res"},{"key":"1431_CR40","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ejca.2004.12.031","volume":"41","author":"A Enns","year":"2005","unstructured":"Enns A, Korb T, Schluter K, Gassmann P, Spiegel HU, Senninger N, Mitjans F, Haier J: Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer. 2005, 41: 1065-1072. 10.1016\/j.ejca.2004.12.031","journal-title":"Eur J Cancer"},{"key":"1431_CR41","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1038\/sj.onc.1210429","volume":"26","author":"NP McCabe","year":"2007","unstructured":"McCabe NP, De S, Vasanji A, Brainard J, Byzova TV: Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. Oncogene. 2007, 26: 6238-6243. 10.1038\/sj.onc.1210429","journal-title":"Oncogene"},{"key":"1431_CR42","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1593\/neo.08740","volume":"10","author":"CN Landen","year":"2008","unstructured":"Landen CN, Kim TJ, Lin YG, Merritt WM, Kamat AA, Han LY, Spannuth WA, Nick AM, Jennnings NB, Kinch MS, Tice D, Sood AK: Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer. Neoplasia. 2008, 10: 1259-1267.","journal-title":"Neoplasia"},{"key":"1431_CR43","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nrd3266","volume":"9","author":"D Cox","year":"2010","unstructured":"Cox D, Brennan M, Moran N: Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov. 2010, 9: 804-820. 10.1038\/nrd3266","journal-title":"Nat Rev Drug Discov"},{"key":"1431_CR44","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/1947601912450586","volume":"2","author":"DA Reardon","year":"2011","unstructured":"Reardon DA, Cheresh D: Cilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies. Genes Cancer. 2011, 2: 1159-1165. 10.1177\/1947601912450586","journal-title":"Genes Cancer"},{"key":"1431_CR45","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/sj.bjc.6605689","volume":"102","author":"T Wang","year":"2010","unstructured":"Wang T, Hu HS, Feng YX, Shi J, Li N, Guo WX, Xue J, Xie D, Liu SR, Wu MC, Cheng SQ: Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer. 2010, 102: 1618-1626. 10.1038\/sj.bjc.6605689","journal-title":"Br J Cancer"},{"key":"1431_CR46","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/humu.21182","volume":"31","author":"C Otten","year":"2010","unstructured":"Otten C, Hansen U, Talke A, Wagener R, Paulsson M, Zaucke F: A matrilin-3 mutation associated with osteoarthritis does not affect collagen affinity but promotes the formation of wider cartilage collagen fibrils. Hum Mutat. 2010, 31: 254-263. 10.1002\/humu.21182","journal-title":"Hum Mutat"},{"key":"1431_CR47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994, 124: 619-626. 10.1083\/jcb.124.4.619","journal-title":"J Cell Biol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:06:26Z","timestamp":1630562786000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-226","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]},"assertion":[{"value":"10 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"226"}}